Bookbot

Cancer Immunology

Parameters

  • 597bladzijden
  • 21 uur lezen

Meer over het boek

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume is focused on immunopathology of cancers. The interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the most recent research and new developments in the field. Over the past decade, understanding of the interactions between the immune system and cancerous cells has increased markedly, leading to the development of combinatorial immunotherapeutic strategies to combat cancer. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists.

Een boek kopen

Cancer Immunology, Nima Rezaei

Taal
Jaar van publicatie
2015
Bindwijze
(Hardcover),
Staat van het boek
Zeer goed
Prijs
€ 171,99

Betaalmethoden

Nog niemand heeft beoordeeld.Tarief

Titel
Cancer Immunology
Taal
Engels
Uitgever
Springer
Jaar van publicatie
2015
Formaat
Hardcover
Aantal pagina's
597
ISBN10
3662440059
ISBN13
9783662440056
Reeks
Aantekening
Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume is focused on immunopathology of cancers. The interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the most recent research and new developments in the field. Over the past decade, understanding of the interactions between the immune system and cancerous cells has increased markedly, leading to the development of combinatorial immunotherapeutic strategies to combat cancer. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists.